NOTCH1 and neoplasm: Silencing Notch1 signaling or HIF-1α inhibition showed a notable anti-growth effect in early treatment with doxycycline or chetomin, indicating that HIF-1α might be a promising therapeutic target even in an early stage of tumor progression.